San Francisco, CANCT03948490Now EnrollingIRB Ready

Low-grade Glioma Clinical Trial in San Francisco, CA

Access cutting-edge low-grade glioma treatment through this clinical trial at a research site in San Francisco. Study-provided care at no cost to qualified participants.

Sponsored by University of California, San Francisco

Quick Self-Assessment

See if you qualify for this San Francisco location

Preparing your pre-screening questions…

Expert Care in San Francisco

Access low-grade glioma specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related low-grade glioma treatment provided free

Apply for This San Francisco Location

Check if you qualify for this low-grade glioma clinical trial in San Francisco, CA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to San Francisco

    Convenient for CA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit San Francisco site if eligible
  4. 4Begin participation

About This Low-grade Glioma Study in San Francisco

Patients with glial brain tumors have increasingly improved outcomes, with median survival of 5-15 years. However, the treatments, including surgery, radiation, and chemotherapy, often lead to impaired attention, working memory, and other cognitive functions. These cognitive deficits frequently have significant impact on patient quality of life. Although currently, there is no established standard of care to treat cognitive deficits in brain tumor patients, standard cognitive rehabilitative treatments have been developed for those with traumatic brain injury and stroke. However, the feasibility and efficacy of these cognitive treatments in individuals with brain tumors remains unclear.

Sponsor: University of California, San Francisco

Who Can Participate

Inclusion Criteria

Histologically confirmed low grade supratentorial primary brain tumor
\>= 18 years old
Life expectancy \> 12 weeks
Karnofsky performance status (KPS) \>= 70
Must speak and be able to read English fluently
Must have access to the internet
Must have text enabled cellphone
Must be receiving MRI scans at University of California, San Francisco (UCSF)
Must be clinically stable and off treatment (e.g. radiation or chemotherapy) for ≥ 3 months
Must be \>= 6 months from craniotomy
Must have subjective complaints of cognitive deficits
Must have adequate seizure control and be on a stable, or decreasing, dose of anti-epileptics
Must score \<= 1 SD below normal on ≥ 2 or more domains of baseline neuropsychological assessments

Exclusion Criteria

Diagnosis or evidence of any of the following:
• Glioblastoma
• Extra-axial disease (i.e. meningioma)
• Infra-tentorial disease
Are not able to comply with study and/or follow-up procedures
Are unable to complete or score \>= 3 cognitive tests at baseline, which is indicative that patients would be unable to complete the cognitive rehabilitation interventions
Are acutely suicidal, psychotic, and/or gravely disabled.
Patients who, based on the neuropsychologist's opinion, are unable to participate in cognitive testing and/or cognitive rehab secondary to significant neurologic deficit Arm 2: Inclusion Criteria:
Have a presumed low grade primary brain tumor and either be undergoing definitive surgery or have had surgical resection within the last 4 months.
Prior surgery is allowed if they have not received additional tumor directed treatment.
\>= 18 years old
Must speak and be able to read English fluently.
Plan to continue to care in neuro-oncology at UCSF
Must be receiving MRI scans. Exclusion Criteria:
Diagnosis or evidence of any of the following:
• Glioblastoma
• Extra-axial disease (i.e. meningioma)
Are not able to comply with study and/or follow-up procedures
Have acute psychiatric issues (suicidality, active psychosis, gravely disabled)

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in San Francisco?

Yes, this clinical trial (NCT03948490) has an active research site in San Francisco, CA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Low-grade Glioma Treatment Options in San Francisco, CA

If you're searching for low-grade glioma treatment options in San Francisco, CA, this clinical trial (NCT03948490) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our San Francisco research site is actively enrolling participants for this clinical trial. You'll receive care from experienced low-grade glioma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all low-grade glioma clinical trials near you to find additional studies recruiting in your area.

More Brain Cancer Trials in San Francisco, CA

See all brain cancer clinical trials recruiting in San Francisco — not just this study.

Browse Brain Cancer Trials in San Francisco →

Ready to Join in San Francisco?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · San Francisco, CA